相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109 Secondary Analysis of a Randomized Clinical Trial
Kevin W. Garey et al.
JAMA NETWORK OPEN (2023)
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Paul Feuerstadt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial
Stuart H. Cohen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life
Richard L. Hengel et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2022)
Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis
Palna Mehta et al.
CLINICAL INFECTIOUS DISEASES (2021)
Burden of Clostridioides difficile infection (CDI)-a systematic review of the epidemiology of primary and recurrent CDI
Elaine Finn et al.
BMC INFECTIOUS DISEASES (2021)
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
Stuart Johnson et al.
CLINICAL INFECTIOUS DISEASES (2021)
Clostridium difficile Infection Hospitalizations in the United States: Insights From the 2017 National Inpatient Sample
Dhanshree Solanki et al.
GASTROENTEROLOGY RESEARCH (2021)
Trends in US Burden of Clostridioides difficile Infection and Outcomes
Alice Y. Guh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Risk Factors Associated with Recurrent Clostridioides difficile Infection
Nicoleta Negrut et al.
HEALTHCARE (2020)
Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients
Hamzah Abu-Sbeih et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2018)
Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey
Kirstin Heinrich et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease
George Saffouri et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Withholding Proton Pump Inhibitors to Prevent Recurrent Clostridium difficile Time for a Randomized Trial
Scott R. Bauer et al.
JAMA INTERNAL MEDICINE (2017)
Are Microbial Politics Local?
Elizabeth L. Hohmann
ANNALS OF INTERNAL MEDICINE (2016)
National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals
Ashley Pechal et al.
BMC INFECTIOUS DISEASES (2016)
Clostridium difficile Infection Is Associated With Poor Outcomes in End-Stage Renal Disease
Chaitanya Pant et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Hospital-Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients
J. P. Donnelly et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
Casey M. Theriot et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
Abhishek Deshpande et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Outcomes in community-acquired Clostridium difficile infection
S. Khanna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
Abhishek Deshpande et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
IBD Poor outcomes after Clostridium difficile infection in IBD
Sahil Khanna et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting
Rada Shakov et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
分享论文
